Dennis S. Charney
Icahn School of Medicine at Mount Sinai
822 Papers
11.8K Citations
Dennis S. Charney is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Anxiety & Medicine. The author has an hindex of 179, co-authored 802 publications. Previous affiliations of Dennis S. Charney include Mount Sinai Hospital & Veterans Health Administration.
Chat about Author
Papers
Habenula volume in post-traumatic stress disorder measured with high-resolution MRI
Jonathan Savitz,Jonathan Savitz,Omer Bonne,Allison C. Nugent,Meena Vythilingam,Wendy Bogers,Dennis S. Charney,Wayne C. Drevets,Wayne C. Drevets +8 more
- 12 Oct 2011
TL;DR: It is suggested that PTSD is not associated with robust structural changes in the habenula, and post hoc analyses controlling for the effects of comorbid major depressive disorder and type and age of trauma exposure were not significant.
Pharmacotherapy of Early-Onset Depression. Update and New Directions
TL;DR: In this article, the evolving study of early-onset depression is discussed, and empiric support for currently available compounds is reviewed, and a pharmacologic treatment algorithm is proposed.
35
A Consensus Meeting on Effective Research Practice in PTSD
Dennis S. Charney,Jonathan R. T. Davidson,Matthew J. Friedman,Rajinder Judge,Terry Keane,Sandy McFarlane,Ferenc Martenyi,Thomas A. Mellman,Frederick Petty,John Plewes,Frank W. Putnam,Steve Romano,Bessel A. van der Kolk,Rachel Yehuda,Joseph Zohar +14 more
TL;DR: The aim of this meeting was to obtain a consensus on what constitutes good research practice in posttraumatic stress disorder (PTSD) as mentioned in this paper, and to reach consensus on the most appropriate parameters to use in future research.
34
Platelet alpha-2-receptor binding and adenylate cyclase activity in panic disorder.
TL;DR: Results are consistent with a dysfunction in some panic disorder patients at the level of the stimulatory GTP binding regulatory protein, Gs, or the adenylate cyclase catalytic unit.
34
Long-term outcome of panic disorder after short-term imipramine and behavioral group treatment: 2.9-year naturalistic follow-up study.
TL;DR: It is suggested that improvement observed after 4 months of treatment with imipramine and behavioral therapy is maintained after 1 to 5 years, even for many patients who reduced the dose of or discontinued imipramsine.
34